A detailed history of Principal Securities, Inc. transactions in Grifols Sa stock. As of the latest transaction made, Principal Securities, Inc. holds 246 shares of GRFS stock, worth $2,140. This represents 0.0% of its overall portfolio holdings.

Number of Shares
246
Previous 230 6.96%
Holding current value
$2,140
Previous $1.45 Million 50.62%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

BUY
$6.28 - $9.38 $100 - $150
16 Added 6.96%
246 $2.18 Million
Q2 2024

Jul 31, 2024

BUY
$6.27 - $7.7 $463 - $569
74 Added 47.44%
230 $1.45 Million
Q1 2024

May 10, 2024

SELL
$5.47 - $11.38 $38 - $79
-7 Reduced 4.29%
156 $1.04 Million
Q4 2023

Feb 07, 2024

BUY
$7.71 - $11.56 $1,256 - $1,884
163 New
163 $1.88 Million

Others Institutions Holding GRFS

About Grifols SA


  • Ticker GRFS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 678,910,976
  • Market Cap $5.91B
  • Description
  • Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...
More about GRFS
Track This Portfolio

Track Principal Securities, Inc. Portfolio

Follow Principal Securities, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Principal Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Principal Securities, Inc. with notifications on news.